Data on 4,902 postmenopausal women without diabetes revealed those whose fasting glucose levels were in the highest third had an increased risk of colorectal cancer, with the effect more pronounced for colon cancer, compared with those in the lowest third. The findings in the British Journal of Cancer suggest that high fasting glucose levels, and not hyperinsulinemia, was associated with colorectal cancer.

Related Summaries